118 related articles for article (PubMed ID: 12351899)
1. Crystallization of HLA-DR4 fused to an immunodominant collagen II peptide implicated in rheumatoid arthritis.
Hurlbert JC; Izard T
Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 1):1749-51. PubMed ID: 12351899
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
3. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
[TBL] [Abstract][Full Text] [Related]
4. Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen.
Rosloniec EF; Ivey RA; Whittington KB; Kang AH; Park HW
J Immunol; 2006 Sep; 177(6):3884-92. PubMed ID: 16951351
[TBL] [Abstract][Full Text] [Related]
5. Effects of type II collagen epitope carbamylation and citrullination in human leucocyte antigen (HLA)-DR4(+) monozygotic twins discordant for rheumatoid arthritis.
De Santis M; Ceribelli A; Cavaciocchi F; Generali E; Massarotti M; Isailovic N; Crotti C; Scherer HU; Montecucco C; Selmi C
Clin Exp Immunol; 2016 Sep; 185(3):309-19. PubMed ID: 27314557
[TBL] [Abstract][Full Text] [Related]
6. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.
Andersson EC; Hansen BE; Jacobsen H; Madsen LS; Andersen CB; Engberg J; Rothbard JB; McDevitt GS; Malmström V; Holmdahl R; Svejgaard A; Fugger L
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7574-9. PubMed ID: 9636191
[TBL] [Abstract][Full Text] [Related]
7. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
[TBL] [Abstract][Full Text] [Related]
8. HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition.
Amria S; Hajiaghamohseni LM; Harbeson C; Zhao D; Goldstein O; Blum JS; Haque A
Eur J Immunol; 2008 Jul; 38(7):1961-70. PubMed ID: 18506881
[TBL] [Abstract][Full Text] [Related]
9. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles.
Cope AP; Patel SD; Hall F; Congia M; Hubers HA; Verheijden GF; Boots AM; Menon R; Trucco M; Rijnders AW; Sønderstrup G
Arthritis Rheum; 1999 Jul; 42(7):1497-507. PubMed ID: 10403279
[TBL] [Abstract][Full Text] [Related]
10. T cell immunity to type II collagen in the biobreeding rat: the identification and characterization of RT1u-restricted T cell epitopes on alpha 1(II).
Cremer MA; Ye XJ; Myers LK; Brand DD; Rosloniec EF; Kang AH
J Immunol; 2004 Aug; 173(3):1795-801. PubMed ID: 15265910
[TBL] [Abstract][Full Text] [Related]
11. Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis.
Kotzin BL; Falta MT; Crawford F; Rosloniec EF; Bill J; Marrack P; Kappler J
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):291-6. PubMed ID: 10618411
[TBL] [Abstract][Full Text] [Related]
12. Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes.
Hall FC; Rabinowitz JD; Busch R; Visconti KC; Belmares M; Patil NS; Cope AP; Patel S; McConnell HM; Mellins ED; Sonderstrup G
Eur J Immunol; 2002 Mar; 32(3):662-70. PubMed ID: 11857340
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
14. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II.
Dessen A; Lawrence CM; Cupo S; Zaller DM; Wiley DC
Immunity; 1997 Oct; 7(4):473-81. PubMed ID: 9354468
[TBL] [Abstract][Full Text] [Related]
15. T cell selection and differential activation on structurally related HLA-DR4 ligands.
Gebe JA; Novak EJ; Kwok WW; Farr AG; Nepom GT; Buckner JH
J Immunol; 2001 Sep; 167(6):3250-6. PubMed ID: 11544312
[TBL] [Abstract][Full Text] [Related]
16. Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses.
Fridkis-Hareli M; Rosloniec EF; Fugger L; Strominger JL
Hum Immunol; 2000 Jul; 61(7):640-50. PubMed ID: 10880734
[TBL] [Abstract][Full Text] [Related]
17. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
Rosloniec EF; Brand DD; Myers LK; Esaki Y; Whittington KB; Zaller DM; Woods A; Stuart JM; Kang AH
J Immunol; 1998 Mar; 160(6):2573-8. PubMed ID: 9510154
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.
Patil NS; Pashine A; Belmares MP; Liu W; Kaneshiro B; Rabinowitz J; McConnell H; Mellins ED
J Immunol; 2001 Dec; 167(12):7157-68. PubMed ID: 11739539
[TBL] [Abstract][Full Text] [Related]
19. Association of MHC and rheumatoid arthritis. HLA-DR4 and rheumatoid arthritis: studies in mice and men.
Fugger L; Svejgaard A
Arthritis Res; 2000; 2(3):208-11. PubMed ID: 11094431
[TBL] [Abstract][Full Text] [Related]
20. Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis.
Di Sante G; Tolusso B; Fedele AL; Gremese E; Alivernini S; Nicolò C; Ria F; Ferraccioli G
EBioMedicine; 2015 Dec; 2(12):2037-45. PubMed ID: 26844284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
